Several industrial players are focusing on the expansion of their products and services. In May 2025, Elis Bio (spun-out of the University of Chiacago) announced the launch of SuperMethyl™, a fast bisulfite conversion kit which provides 99.5% methyl conversion within ten minutes, in 2024 Chicago BioCapital Summit. Earlier, in August 2024, Genentech signed a licensing agreement worth up to USD 2 billion with Sangamo Therapeutics to develop genomic medicines for treating neurodegenerative diseas...

The global healthcare cold chain logistics market is estimated to grow from USD 197.7 billion in 2024 to reach USD 207.0 billion in 2025 and USD 320.9 billion by 2035, representing a higher CAGR of 4.5% during the forecast period. Given the recent technical breakthroughs and advances, and the steadily rising demand for biopharmaceuticals, the reliance on cold chain is expected to increase substantially, causing logistics service providers to contemplate, devise and implement flexible business st...

The widespread adoption of DNA methylation technologies and broad emphasis on genome research have become crucial growth factors for this industry. It is worth noting that industrial players, such as Pfizer, Roche, QIAGEN are finding key opportunities in this field and focusing on technological innovations to make them more advanced and affordable. For instance, in April 2025, EpiCypher® (a global leader in epigenomic innovation) launched CUTANA® meCUT&RUN and Multiomic CUT&RUN (affordable met...

The industrial players such as Merck, Thermo Fisher Scientific and STEMCELL Technologies are increasingly emphasizing adult stem cells specifically those collected from adipose tissues / bone marrow to repair tissue damage and development of stem cell therapies for targeting wide range of diseases. In April 2025, Abu Dhabi Biobank launched an affordable private cord blood banking which offers an affordable and accessible way to preserve their newborns stem cells.

The global market for cryopreservation bags and freezing bags, valued at USD 216 million in 2025, is projected to reach USD 224 million in 2026 and USD 316 million by 2035, with a 3.9% CAGR during the forecast period 2026 to 2035. The cryopreservation bags and freezing bags providers landscape features a mix of large, mid-sized and small companies that offer various cryobags. Presently, more than 70 cryogenic storage bags for biologic products have been / are being developed by over 30 industry...

Currently, the global market for glycobiology is valued at USD 1.95 billion in 2025 and is poised to reach USD 6.77 billion by 2035, representing a CAGR of 13.2% during the forecast period. This lucrative growth is likely to be the result of increasing research on glycomics.To leverage the competitive edge, several industrial players are driving innovations, investments and partnerships in this field. For instance, in December 2024, GlycoNet (global leader in glycomics research and innovations)...

The biopreservation market for media, valued at USD 1.9 billion in 2025, is projected to reach USD 2.3 billion in 2026 and USD 15.5 billion by 2035, with a 23.6% CAGR during the forecast period 2026 to 2035. At present, over 60 players claim to offer more than 190 biopreservation and biobanking, intended for storage and preservation of different types of biological samples. Further, as per a study conducted by the USFDA, across more than 80% submissions for mesenchymal cell-based therapies, it w...

The global immuno-oncology drugs market, valued at USD 80.82 billion in 2024, is projected to reach USD 97.52 billion in 2025 and USD 442.26 billion by 2035, representing a CAGR of 16.3% during the forecast period. Driven by the ongoing initiatives and accelerated approval, we believe that immuno-oncology drugs market will continue to grow at a steady pace during the forecast period.

The metagenomic sequencing market size is estimated to grow from USD 2.20 billion in 2024 to USD 2.55 billion in 2025 and USD 8.63 billion by 2035, representing a CAGR of 13.0% during the forecast period. Based on the type of offering, the global market is segmented into reagents and consumables, instruments, and sequencing & data analytics services. According to metagenomic sequencing market forecast, presently reagents and consumables hold the highest share of the market. This can be attribute...

The global bioprocess analyzers market, valued at USD 2.58 billion in 2024, is projected to reach USD 2.88 billion in 2025 and USD 7.23 billion by 2035, representing a CAGR of 9.6% during the forecast period. Owing to the increasing initiatives by industrial players, we believe that bioprocess analyzer market is expected to grow at a steady rate during the forecast period.

The global single cell multi-omics market, valued at USD 3.18 billion in 2024, is expected to reach USD 3.93 billion in 2025 and USD 21.13 billion by 2035, representing a higher CAGR of 18.3% during the forecast period. Based on the type of product, the global market is segmented into instruments and consumables. According to our single cell multi-omics market analysis, the instruments segment accounts for the largest market share. It is worth mentioning here that the trend of dominance will con...

The global epigenomics market, valued at USD 1.98 billion in 2024, is projected to reach USD 2.32 billion in 2025 and USD 8.49 billion by 2035, representing a CAGR of 13.8% during the forecast period. With growing usage across healthcare industry, various industrial players are focusing on the development of advanced products, instruments, and services.

The global tangential flow filtration market, valued at USD 1.59 billion in 2024, is projected to reach USD 1.80 billion in 2025 and USD 5.50 billion by 2035, representing a CAGR of 11.82% during the forecast period. Currently, single-use tangential flow filtration systems segment accounts for the highest share (52%) of the market. This is potentially due to the growing adoption of single-use technologies for the manufacturing of biologics in pharmaceutical industries.

The global single cell analysis market size, valued at USD 4.29 billion in 2024, is projected to reach USD 5.08 billion in 2025 and USD 19.90 billion by 2035, representing a CAGR of 14.6% during the forecast period. Currently, data analysis accounts for the highest single cell analysis market share (nearly 40%). This can be attributed to the growing requirement for advanced data analytic solutions to analyze and store vast amount of data generated from single cell analysis.

The global bioinformatics services market, valued at USD 3.49 billion in 2024, is projected to reach USD 4.09 billion in 2025 and USD 14.94 billion by 2035, representing a CAGR of 13.8% during the forecast period. According to our projection, presently pharmaceutical & biotechnology companies hold the largest bioinformatics services market share (45%). This can be attributed to the increasing genomic research, disease studies and drug discovery & development for wide range of disease indications...

The global natural language processing (NLP) in healthcare and life sciences market, valued at USD 3.26 billion in 2024, is projected to reach USD 3.99 billion in 2025 and USD 20.04 billion by 2035, representing a CAGR of 17.5% during the forecast period. Examples of key players engaged in this domain (which have also been captured in this report) include 10x Genomics, Amazon, Caresyntax, Cerner, Mayo Clinic, Epic Systems, Google, Health Catalyst, IBM, Invitae, Microsoft, Nuance Communications,...

The global single-cell omics market is estimated to grow from USD 3.89 billion in 2025 to USD 17.01 billion by 2035, representing a CAGR of 15.90% during the forecast period. Based on the type of product, the global market is segmented into instruments and consumables. According to our analysis, presently instruments hold the highest share (nearly 60%) of the market and this segment is likely to remain dominant over the forecast period. Instruments, such as flow cytometers, single-cell RNA seque...

The global Mass Spectrometry market is expected to grow from USD 6.4 billion in 2024 to USD 14.6 billion by 2035. The market is anticipated to grow at a CAGR of 7.7% during the forecast period, till 2035. The market for instruments is currently the leading segment, holding 78% of the market share. Whereas the service segment is anticipated to contribute notably to the mass spectrometry market growth over this projection period. According to our projection, hybrid mass spectrometry accounts for...

The global single nucleotide polymorphism (SNP) genotyping market is expected to grow from USD 12.9 billion in 2025 to USD 61.1 billion by 2035, representing a CAGR of 16.84% during the forecast period. One of the significant single nucleotide polymorphisms (SNP) genotyping market driver is rising incidence of chronic diseases such as diabetes and cancer. According to the National Cancer Institute, in 2024, nearly 14,910 children and adolescents aged (0-19 years) will be diagnosed with cancer. T...

The global genomics market size, valued at USD 38.77 billion in 2024, is expected to reach USD 46.06 billion in 2025 and USD 186.64 billion by 2035, representing a compounded annual growth rate (CAGR) of 15.0% during the forecast period. Some of the potential market drivers that are anticipated to drive the genomics market growth includes rising prevalence of cancer and growing adoption of next generation sequencing in cancer research. As per the cancer statistics published by American Cancer So...